Cargando…
Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies
In the search of biguanide-derived molecules against melanoma, we have discovered and developed a series of bioactive products and identified the promising new compound CRO15. This molecule exerted anti-melanoma effects on cells lines and cells isolated from patients including the ones derived from...
Autores principales: | Jaune, Emilie, Cavazza, Elisa, Ronco, Cyril, Grytsai, Oleksandr, Abbe, Patricia, Tekaya, Nedra, Zerhouni, Marwa, Beranger, Guillaume, Kaminski, Lisa, Bost, Frédéric, Gesson, Maeva, Tulic, Meri, Hofman, Paul, Ballotti, Robert, Passeron, Thierry, Botton, Thomas, Benhida, Rachid, Rocchi, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801734/ https://www.ncbi.nlm.nih.gov/pubmed/33431809 http://dx.doi.org/10.1038/s41419-020-03344-6 |
Ejemplares similares
-
E2F1 inhibition mediates cell death of metastatic melanoma
por: Rouaud, Florian, et al.
Publicado: (2018) -
ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity
por: Cheli, Yann, et al.
Publicado: (2021) -
Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity
por: Cheli, Yann, et al.
Publicado: (2021) -
Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo
por: Tulic, Meri K., et al.
Publicado: (2019) -
Metformin: Focus on Melanoma
por: Jaune, Emilie, et al.
Publicado: (2018)